{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:50:27Z","timestamp":1781189427150,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.abrep.2024.100553","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:53:03Z","timestamp":1715701983000},"page":"100553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Mortality, morbidity, and predictors of death among amphetamine-type stimulant users \u2212 a longitudinal, nationwide register study"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-1397","authenticated-orcid":false,"given":"A.","family":"\u00c5hman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1131-3726","authenticated-orcid":false,"given":"A.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5800-8975","authenticated-orcid":false,"given":"A.","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abrep.2024.100553_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2018.03.053","article-title":"Mortality and causes of death among people who inject amphetamine: A long-term follow-up cohort study from a needle exchange program in Sweden","volume":"188","author":"\u00c5hman","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.abrep.2024.100553_b0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and Methamphetamine Injection: An emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Substance Use & Misuse"},{"issue":"2\u20133","key":"10.1016\/j.abrep.2024.100553_b0015","first-page":"134","article-title":"Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment","volume":"114","author":"Arendt","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.abrep.2024.100553_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1360-0443.2004.00602.x","article-title":"Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia","volume":"99","author":"Bartu","year":"2004","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.abrep.2024.100553_b0025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"European Journal of Epidemiology"},{"issue":"6","key":"10.1016\/j.abrep.2024.100553_b0030","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/dar.12840","article-title":"Amphetamine use in the fourth decade of life: Social profiles from a population-based Australian cohort","volume":"37","author":"Butterworth","year":"2018","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"10.1016\/j.abrep.2024.100553_b0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08897077.2012.726959","article-title":"National trends in psychostimulant-related deaths: 1999\u20132009","volume":"34","author":"Calcaterra","year":"2013","journal-title":"Substance Abuse"},{"key":"10.1016\/j.abrep.2024.100553_b0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2018.03.030","article-title":"Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study","volume":"188","author":"Callaghan","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.abrep.2024.100553_b0045","series-title":"Mortality amongst illicit drug users: Epidemiology, causes and interventions","author":"Darke","year":"2006"},{"key":"10.1016\/j.abrep.2024.100553_b0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugalcdep.2017.07.001","article-title":"Prevalence and nature of cardiovascular disease in methamphetamine-related death: A national study","volume":"179","author":"Darke","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.abrep.2024.100553_b0055","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/add.13897","article-title":"Rates, characteristics and circumstances of methamphetamine-related death in Australia: A national 7-year study","volume":"112","author":"Darke","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.abrep.2024.100553_b0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/09595230801923702","article-title":"Major physical and psychological harms of methamphetamine use","volume":"27","author":"Darke","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.abrep.2024.100553_b0065","unstructured":"Dean, A., Sullivan, K., & Soe, M. (2013). OpenEpi: Open Source Epidemiologic Statistics for Public Health. https:\/\/www.openepi.com\/SMR\/SMR.htm."},{"issue":"1\u20132","key":"10.1016\/j.abrep.2024.100553_b0070","first-page":"71","article-title":"Simultaneous use of non-medical ADHD prescription stimulants and alcohol among undergraduate students","volume":"131","author":"Egan","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.abrep.2024.100553_b0075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/10826084.2013.825921","article-title":"Mortality, causes of death and risk factors for death among primary amphetamine users in the swedish criminal justice system","volume":"49","author":"Ericsson","year":"2014","journal-title":"Substance Use & Misuse"},{"issue":"10209","key":"10.1016\/j.abrep.2024.100553_b0080","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: Challenges and opportunities","volume":"394","author":"Farrell","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.abrep.2024.100553_b0085","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.abrep.2024.100553_b0090","doi-asserted-by":"crossref","first-page":"e0253710-","DOI":"10.1371\/journal.pone.0253710","article-title":"Mortality among amphetamine users with hepatitis C virus infection: A nationwide study","volume":"16","author":"Gahrton","year":"2021","journal-title":"PLoS One1"},{"issue":"5","key":"10.1016\/j.abrep.2024.100553_b0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/00952990.2011.602995","article-title":"Rates and influences of alcohol use disorder comorbidity among primary stimulant misusing treatment-seekers: Meta-analytic findings across eight NIDA CTN trials","volume":"37","author":"Hartzler","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1016\/j.abrep.2024.100553_b0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present \u2013 a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"Journal of Psychopharmacology"},{"issue":"7","key":"10.1016\/j.abrep.2024.100553_b0105","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/sim.4780090710","article-title":"More powerful procedures for multiple significance testing","volume":"9","author":"Hochberg","year":"1990","journal-title":"Statistics in Medicine"},{"issue":"1","key":"10.1016\/j.abrep.2024.100553_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12012-016-9385-8","article-title":"Exposure to amphetamines leads to development of amphetamine type stimulants associated cardiomyopathy (ATSAC)","volume":"17","author":"Jafari Giv","year":"2017","journal-title":"Cardiovascular Toxicology"},{"issue":"10","key":"10.1016\/j.abrep.2024.100553_b0115","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/23744235.2017.1334263","article-title":"Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program","volume":"49","author":"K\u00e5berg","year":"2017","journal-title":"Infectious Diseases"},{"issue":"8","key":"10.1016\/j.abrep.2024.100553_b0120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.2008.02231.x","article-title":"Methamphetamine-related fatalities in Australia: Demographics, circumstances, toxicology and major organ pathology","volume":"103","author":"Kaye","year":"2008","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.abrep.2024.100553_b0125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1360-0443.2007.01874.x","article-title":"Methamphetamine and cardiovascular pathology: A review of the evidence","volume":"102","author":"Kaye","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.abrep.2024.100553_b0130","series-title":"International encyclopedia of public health","first-page":"295","article-title":"Observational epidemiology","author":"Kelsey","year":"2017"},{"key":"10.1016\/j.abrep.2024.100553_b0135","series-title":"Survival analysis: A self-learning text","author":"Kleinbaum","year":"2012"},{"issue":"6","key":"10.1016\/j.abrep.2024.100553_b0140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1465-3362.2010.00255.x","article-title":"Causes of death of patients with methamphetamine dependence: A record-linkage study","volume":"30","author":"Kuo","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.abrep.2024.100553_b0145","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"9","key":"10.1016\/j.abrep.2024.100553_b0150","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/j.1360-0443.2005.01160.x","article-title":"The nature, time course and severity of methamphetamine withdrawal","volume":"100","author":"McGregor","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.abrep.2024.100553_b0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eclinm.2019.09.014","article-title":"Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis","volume":"16","author":"McKetin","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"S3","key":"10.1016\/j.abrep.2024.100553_b0160","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.5694\/j.1326-5377.2011.tb03266.x","article-title":"Major depression among methamphetamine users entering drug treatment programs","volume":"195","author":"McKetin","year":"2011","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"10.1016\/j.abrep.2024.100553_b0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2005.04.012","article-title":"Heroin overdose among young injection drug users in San Francisco","volume":"80","author":"Ochoa","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.abrep.2024.100553_b0170","unstructured":"Public Health Agency of Sweden. (2023). HIV and STIs. Public Health Agency of Sweden. https:\/\/www.folkhalsomyndigheten.se\/the-public-health-agency-of-sweden\/living-conditions-and-lifestyle\/hiv-and-stis."},{"issue":"1","key":"10.1016\/j.abrep.2024.100553_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.05.028","article-title":"Mortality among amphetamine users: A systematic review of cohort studies","volume":"105","author":"Singleton","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.abrep.2024.100553_b0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1465-3362.2009.00075.x","article-title":"Mortality and cause of death among 1705 illicit drug users: A 37 year follow up","volume":"29","author":"Stenbacka","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"10","key":"10.1016\/j.abrep.2024.100553_b0185","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/add.14706","article-title":"Mortality among people with regular or problematic use of amphetamines: A systematic review and meta-analysis","volume":"114","author":"Stockings","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.abrep.2024.100553_b0190","unstructured":"The Swedish National Board of Health and Welfare. (2022). Det statistiska registrets framst\u00e4llning och kvalitet: D\u00f6dsorsaksregistret . The Swedish National Board of Health and Welfare. https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/statistik\/2022-5-7909.pdf."},{"key":"10.1016\/j.abrep.2024.100553_b0195","unstructured":"The Swedish National Board of Health and Welfare. (2024). Statistikdatabas f\u00f6r d\u00f6dsorsaker. The Swedish National Board of Health and Welfare. https:\/\/sdb.socialstyrelsen.se\/if_dor\/val.aspx."},{"issue":"5","key":"10.1016\/j.abrep.2024.100553_b0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.15288\/jsad.2018.79.799","article-title":"Polysubstance use by stimulant users: Health outcomes over three years","volume":"79","author":"Timko","year":"2018","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.abrep.2024.100553_b0205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.drugalcdep.2017.12.030","article-title":"Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005\u20132015","volume":"185","author":"Turner","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.abrep.2024.100553_b0210","unstructured":"United Nations Office on Drugs and Crime. (n.d.). Online World Drug Report 2023 - Latest data and trend analysis. 2023. Retrieved October 11, 2023, from https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr-2023-online-segment.html."},{"issue":"1","key":"10.1016\/j.abrep.2024.100553_b0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2011.12.007","article-title":"Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis","volume":"122","author":"van Emmerik-van Oortmerssen","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.abrep.2024.100553_b0220","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/ije\/26.6.1219","article-title":"Has mortality in drug addicts increased? A comparison between two hospitalized cohorts in Stockholm","volume":"26","author":"Wahren","year":"1997","journal-title":"International Journal of Epidemiology"},{"issue":"13","key":"10.1016\/j.abrep.2024.100553_b0225","article-title":"Polydrug use - prevalence and registration","volume":"139","author":"Walderhaug","year":"2019","journal-title":"Tidsskrift for den Norske L\u00e6geforening"},{"issue":"9","key":"10.1016\/j.abrep.2024.100553_b0230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","article-title":"The size and burden of mental disorders and other disorders of the brain in Europe 2010","volume":"21","author":"Wittchen","year":"2011","journal-title":"European Neuropsychopharmacology"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853224000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853224000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T23:15:25Z","timestamp":1717370125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352853224000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":46,"alternative-id":["S2352853224000300"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2024.100553","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality, morbidity, and predictors of death among amphetamine-type stimulant users \u2212 a longitudinal, nationwide register study","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2024.100553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100553"}}